Testing insulin effects on brain function
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study looks at how giving insulin in a way that mimics the body's natural release can affect thinking and memory. It may help understand how insulin relates to brain health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You scored below 25 on a standard memory test (MMSE).
- You are not taking daily anxiety medicine (like benzodiazepines).
- You are an adult (18 years or older).
- You are not pregnant.
- You are not in prison or have another condition that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
This study looks at a marker of brain insulin resistance in people with mild cognitive impairment (MCI) to see if it can help predict who might develop Alzheimer's disease. If you have MCI and have been treated at the Nancy memory clinic, you may be able to join.
This study tests whether unusual insulin action in the brain is linked to thinking problems and body/metabolic issues in schizophrenia. It may help researchers understand the cause and identify targets for future treatments.
This study looks at how insulin resistance in the brain affects brain health. If you have type 1 or type 2 diabetes and are between 50 and 80 years old, you may be able to join to help researchers understand brain changes.
This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.